RJA
CRDL

Raymond James & Associates’s Cardiol Therapeutics CRDL Stock Holding History

Raymond James & Associates’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,154
Closed -$20.2K – 3935
2024
Q1 		$20.2K Hold
11,154
– – ﹤0.01% 3829
2023
Q4 		$9.41K Buy
+11,154
New +$9.41K ﹤0.01% 3745